Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer

[1]  S. Tatsunami,et al.  Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis. , 2011, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[2]  Sang-We Kim,et al.  Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis. , 2009, Lung cancer.

[3]  J. Rubins,et al.  Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). , 2007, Chest.

[4]  N. Laperriere,et al.  Management of single brain metastasis: a practice guideline , 2007, Current oncology.

[5]  P. Pairolero,et al.  Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. , 2007, The Annals of thoracic surgery.

[6]  W. Alberts,et al.  Follow up and surveillance of the patient with lung cancer: What do you do after surgery? , 2007, Respirology.

[7]  Hiroki Shirato,et al.  Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial , 2007 .

[8]  P. Pairolero,et al.  Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients. , 2006, The Annals of thoracic surgery.

[9]  E. Miyaoka,et al.  Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. , 2005, Lung cancer.

[10]  David E Morris,et al.  The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. , 2005, International journal of radiation oncology, biology, physics.

[11]  A. Yamaura,et al.  Gamma knife surgery for brain metastases: indications for and limitations of a local treatment protocol , 2005, Acta Neurochirurgica.

[12]  P. Jänne,et al.  High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  L. Stangeland,et al.  The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years. , 2005, Lung cancer.

[14]  Roy A Patchell,et al.  The management of brain metastases. , 2003, Cancer treatment reviews.

[15]  P. Kvale,et al.  Lung cancer. Palliative care. , 2003, Chest.

[16]  M. Mehta,et al.  A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. , 2002, International journal of radiation oncology, biology, physics.

[17]  K. Kelly,et al.  Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer? , 1998, Lung cancer.

[18]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[19]  Susan M. Chang,et al.  Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. , 1997, International journal of radiation oncology, biology, physics.

[20]  K. Kubota,et al.  A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis. , 1997, British Journal of Cancer.

[21]  B. Croisile,et al.  A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer. , 1996, European journal of cancer.

[22]  J M Lachin,et al.  Sequential monitoring of survival data with the Wilcoxon statistic. , 1995, Biometrics.

[23]  Y. Ichinose,et al.  Postrecurrent survival of patients with non-small-cell lung cancer undergoing a complete resection. , 1994, The Journal of thoracic and cardiovascular surgery.

[24]  L D Lunsford,et al.  A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. , 1994, International journal of radiation oncology, biology, physics.

[25]  W. J. Lorenz,et al.  Long‐term follow‐up for brain metastases treated by percutaneous stereotactic single high‐dose irradiation , 1993, Cancer.

[26]  C. Lindquist,et al.  Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience. , 1993, Stereotactic and functional neurosurgery.

[27]  J R Adler,et al.  Stereotactic radiosurgical treatment of brain metastases. , 1992, Journal of neurosurgery.

[28]  M. Burt,et al.  Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff. , 1992, The Journal of thoracic and cardiovascular surgery.

[29]  M. Mehta,et al.  Defining the role of radiosurgery in the management of brain metastases. , 1992, International journal of radiation oncology, biology, physics.

[30]  G. Noren,et al.  Gamma knife surgery for cerebral metastasis. , 1991, Acta neurochirurgica. Supplementum.

[31]  L. Deangelis,et al.  Radiation‐induced dementia in patients cured of brain metastases , 1989, Neurology.

[32]  K Takakura,et al.  Subacute brain atrophy after radiation therapy for malignant brain tumor , 1989, Cancer.

[33]  H. Baumel,et al.  Results of Therapy , 1986 .

[34]  R. Gelber,et al.  The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1980, International journal of radiation oncology, biology, physics.